| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656639 | 60370 | PEITEL 2,5 MG/G POMADA | PEITEL 2,5 MG/G POMADA , 1 tubo de 60 g | 2,5 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60370/60370_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60370/60370_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30008 | GALENICUM DERMA S.L.U. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2007-09-10 | 1 | 2011-10-24 | 691600 | View Edit Delete | |||||||||||
| 656642 | 60372 | PEITEL 2,5 MG/G CREMA | PEITEL 2,5 MG/G CREMA , 1 tubo de 30 g | 2,5 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60372/60372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60372/60372_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30008 | GALENICUM DERMA S.L.U. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2007-09-10 | 1 | 2011-10-24 | 691576 | View Edit Delete | |||||||||||
| 656643 | 60372 | PEITEL 2,5 MG/G CREMA | PEITEL 2,5 MG/G CREMA , 1 tubo de 60 g | 2,5 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60372/60372_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60372/60372_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30008 | GALENICUM DERMA S.L.U. | 1994-12-01 | 1 | 1 | 1 | 1994-12-01 | 2007-09-10 | 1 | 2011-10-24 | 691568 | View Edit Delete | |||||||||||
| 656721 | 14534 | LUBRISTESIC 7,5 mg/g POMADA | LUBRISTESIC 7,5 mg/g POMADA, 1 tubo de 25 g | 7,5 mg/g | 44 | 25 | 21 | 1 tubo de 25 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/14534/14534_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/14534/14534_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | GALENICUM DERMA S.L.U. | 1950-12-01 | 1 | 1 | 1 | 1950-12-01 | 1950-12-01 | 1 | 2011-09-28 | 650091 | View Edit Delete | |||||||||||
| 656808 | 41645 | CELECREM 0,5 mg/g CREMA | CELECREM 0,5 mg/g CREMA , 1 tubo de 30 g | 0,5 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41645/41645_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41645/41645_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | GALENICUM DERMA S.L.U. | 1965-10-01 | 1 | 1 | 1 | 1965-10-01 | 2008-09-08 | 1 | 2011-09-28 | 727891 | View Edit Delete | |||||||||||
| 654712 | 06348001 | ROTATEQ SOLUCION ORAL | ROTATEQ SOLUCION ORAL, 1 tubo de 2 ml | N/A (vacuna) | 44 | 1 | 17 | 1 tubo de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06348001/06348001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06348001/06348001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2006-07-12 | 1 | 1 | 1 | 2006-07-12 | 2006-07-12 | 0 | 2011-10-05 | View Edit Delete | ||||||||||||
| 658190 | 68296 | ACICLOVIR SANDOZ CARE 50 MG/G CREMA | ACICLOVIR SANDOZ CARE 50 MG/G CREMA , 1 tubo de 2 g | 50 mg/g | 44 | 2 | 21 | 1 tubo de 2 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68296/68296_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68296/68296_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2006-12-21 | 1 | 1 | 1 | 2006-12-21 | 2006-12-21 | 1 | 2014-05-23 | View Edit Delete | ||||||||||||
| 657882 | 98067002 | MABTHERA 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | MABTHERA 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98067002/98067002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98067002/98067002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 657890 | 98067001 | MABTHERA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | MABTHERA 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 2 | 34 | 2 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98067001/98067001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98067001/98067001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 1998-09-01 | 1 | 1 | 1 | 1998-09-01 | 1998-09-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 656186 | 68087 | PROLASTINA 1000 mg, POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN. | PROLASTINA 1000 mg, POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN. , 1 vial + 1 vial de disolvente | 1.000 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68087/68087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68087/68087_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 2006-10-18 | 1 | 1 | 1 | 2006-10-18 | 2006-10-18 | 1 | 2011-04-25 | View Edit Delete | ||||||||||||
| 656019 | 62002 | NORADRENALINA B. BRAUN 0,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | NORADRENALINA B. BRAUN 0,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 50 ml | 0,5 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62002/62002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62002/62002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 1999-07-01 | 1 | 1 | 1 | 1999-07-01 | 2006-09-14 | 1 | 2011-06-20 | View Edit Delete | ||||||||||||
| 654677 | 67925 | CETRAXAL OTICO 3 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS | CETRAXAL OTICO 3 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS, 20 envases unidosis de 0,4 ml | 3 mg/ml | 45 | 20 | 51 | 20 envases unidosis de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67925/67925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67925/67925_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2006-07-05 | 1 | 1 | 1 | 2006-07-05 | 2006-07-05 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 654791 | 34348 | BENADON 300 mg SOLUCION INYECTABLE | BENADON 300 mg SOLUCION INYECTABLE , 6 ampollas de 2 ml | 300 mg | 45 | 6 | 1 | 6 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34348/34348_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34348/34348_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2896 | TEOFARMA S.R.L. | 1960-09-01 | 1 | 1 | 1 | 1960-09-01 | 2013-06-10 | 1 | 2014-01-02 | 779207, 650105, 656767 | View Edit Delete | |||||||||||
| 656036 | 06346001 | TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | TYSABRI 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml | 300 mg | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06346001/06346001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06346001/06346001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | BIOGEN SPAIN S.L. | 2006-09-26 | 1 | 1 | 1 | 2006-09-26 | 2006-09-26 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 658518 | 96027001 | HYCAMTIN 4 mg POLVO CONCENTRADO PARA SOLUCION PARA PERFUSION | HYCAMTIN 4 mg POLVO CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 viales | 4 mg | 45 | 5 | 34 | 5 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96027001/96027001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96027001/96027001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12611 | BEXAL FARMACEUTICA S.A. | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1998-05-01 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 657445 | 00152005 | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00152005/00152005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00152005/00152005_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | GLAXOSMITHKLINE S.A. | 2001-03-21 | 1 | 1 | 1 | 2001-03-21 | 2001-03-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 657452 | 00152006 | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE | INFANRIX HEXA POLVO Y SUSPENSION PARA SUSPENSION INYECTABLE, 10 viales + 10 jeringas precargadas de disolvente | N/A (vacuna) | 45 | 10 | 34 | 10 viales + 10 jeringas precargadas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00152006/00152006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00152006/00152006_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | GLAXOSMITHKLINE S.A. | 2001-03-21 | 1 | 1 | 1 | 2001-03-21 | 2001-03-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656088 | 04302001 | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION, 1 vial de 1 ml | 100 microgramos/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04302001/04302001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04302001/04302001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2006-10-17 | 1 | 1 | 1 | 2006-10-17 | 2006-10-17 | 1 | 2011-07-20 | View Edit Delete | ||||||||||||
| 656089 | 04302003 | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION | PRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSION, 1 vial de 5 ml | 100 microgramos/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04302003/04302003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04302003/04302003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2006-10-17 | 1 | 1 | 1 | 2006-10-17 | 2006-10-17 | 1 | 2011-07-20 | View Edit Delete | ||||||||||||
| 656764 | 41181 | BRITAPEN 500 MG POLVO PARA SOLUCIÓN PARA INYECCIÓN | BRITAPEN 500 MG POLVO PARA SOLUCIÓN PARA INYECCIÓN, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1965-07-01 | 1 | 1 | 1 | 1965-07-01 | 2008-04-30 | 0 | 2012-01-02 | 720482 | View Edit Delete |
Page 133 of 1035, showing 20 records out of 20697 total, starting on record 2641, ending on 2660